Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine

NCT: NCT07047638 · RECRUITING

NCT IDNCT07047638
StatusRECRUITING
Start Date2025-07-09
Completion2027-07-31

Brief Summary

This is a randomized, evaluator-blinded, no-treatment controlled, study to evaluate the effectiveness and safety of Restylane Skinboosters Vital Lidocaine treatment to improve skin quality of the face in China. Subjects of Chinese origin, age 18 years, who are eligible for treatment to improve skin quality of the face. Study center is up to 8. A total of approximately 171 subjects will be randomized (2:1) to either treatment with Restylane Skinboosters Vital Lidocaine Treatment Group (approximately 114 subjects) or no-treatment Control Group (approximately 57 subjects).

Frequently Asked Questions

What is A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine?

A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine is a clinical trial registered under NCT07047638. Current status: RECRUITING.

What is the status of NCT07047638?

The current status of NCT07047638 (A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine) is: RECRUITING.

When did A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine start?

A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine started on 2025-07-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.